Gp96-Ig/costimulator (OX40L, ICOSL, or 4-1BBL) Combination Vaccine Improves T cell Priming and Enhances Immunity, Memory, and Tumor Elimination Heat Biologics 2017
Viagenpumatucel-L (HS-110) Bolsters Response to Nivolumab Therapy in Advanced Lung Adenocarcinoma: Preliminary Data From The DURGA Trial Heat Biologics 2016
In vivo Intratumoral Electroporation of Gp96-Ig/Fc-OX40L Stimulates CD8+ T cell Cross Priming to Tumor-Specific Neoantigens Heat Biologics 2016
